Business Context and Reporting Period
Entrada Therapeutics, Inc. (TRDA) filed a Current Report on Form 8-K dated March 16, 2022. The filing discloses the entry into a material definitive agreement regarding a new consolidated headquarters in Boston, Massachusetts.
Key Financial Metrics and Obligations
This filing details a long-term lease obligation rather than operational financial performance metrics such as revenue or profit.
- Lease Term: Approximately 10 years, commencing on or about April 1, 2022, with an option to extend for an additional 5 years.
- Space: Approximately 81,442 square feet of office and laboratory space.
- Initial Fixed Rental Rate: $525,416.67 per month (based on 65,000 sq. ft. for the first 12 months), increasing 3% annually thereafter for the full 81,442 sq. ft.
- Landlord Allowance: Up to $19,546,080.00 ($240.00 per sq. ft.) for initial buildout, reflected in base rent.
- Additional Improvement Contribution: Up to $1,628,840.00 ($20.00 per sq. ft.) available for additional improvements, repayable over 120 months at 8% annual interest.
Material Changes
The Company entered into a new Lease Agreement to consolidate its headquarters. This represents a significant new direct financial obligation and off-balance sheet arrangement. The filing does not provide comparative financial data or changes in revenue, margins, or cash flow versus prior periods.
Outlook, Risks, and Contingencies
Management Commentary: The new premises will serve as the Company's consolidated headquarters and supplement existing Massachusetts space. Rent commencement is tied to the Landlord's substantial completion of the initial buildout or 10 months following the Commencement Date, whichever is earlier.
Risks and Contingencies: The Company assumes obligations for operating expenses, taxes, and other lease-related costs. The additional improvement contribution creates a debt-like obligation with interest charges if utilized.
Investor Verification Checklist
- Verify the exact "Commencement Date" once the Landlord tenders possession, as this triggers rent obligations.
- Confirm the total capital expenditure required for the initial buildout versus the $19.5M landlord allowance.
- Assess the impact of the 8% interest rate on the optional $1.6M improvement contribution if the Company elects to use it.
- Review the full Lease Agreement (Exhibit 10.1) for specific termination clauses and operating expense definitions.